In parallel to FasL expression, cancer cells often display resistance to Fas-mediated apoptosis and therefore ‘the Fas counterattack’ concept was introduced to describe the modulation of the Fas–FasL system by tumour cells to favour their immune privilege (O'Connell et al, 1999). This evidence concerns the gene FASLG and cancer.